Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-Venom Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Cytotoxic
  • 1.3.3 Neurotoxic
  • 1.3.4 Haemotoxic
  • 1.3.5 Cardiotoxic
  • 1.3.6 Myotoxic
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-Venom Market Share by Application (2019-2025)
  • 1.4.2 Snake
  • 1.4.3 Spider
  • 1.4.4 Scorpion
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Venom Market Size
  • 2.1.1 Global Anti-Venom Revenue 2014-2025
  • 2.1.2 Global Anti-Venom Sales 2014-2025
• 2.2 Anti-Venom Growth Rate by Regions
  • 2.2.1 Global Anti-Venom Sales by Regions 2014-2019
  • 2.2.2 Global Anti-Venom Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-Venom Sales by Manufacturers
  • 3.1.1 Anti-Venom Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-Venom Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-Venom Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-Venom Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-Venom Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-Venom Price by Manufacturers
• 3.4 Key Manufacturers Anti-Venom Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-Venom Market
• 3.6 Key Manufacturers Anti-Venom Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Cytotoxic Sales and Revenue (2014-2019)
  • 4.1.2 Neurotoxic Sales and Revenue (2014-2019)
  • 4.1.3 Haemotoxic Sales and Revenue (2014-2019)
  • 4.1.4 Cardiotoxic Sales and Revenue (2014-2019)
  • 4.1.5 Myotoxic Sales and Revenue (2014-2019)
• 4.2 Global Anti-Venom Sales Market Share by Type
• 4.3 Global Anti-Venom Revenue Market Share by Type
• 4.4 Anti-Venom Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-Venom Sales by Application

6 United States

• 6.1 United States Anti-Venom Breakdown Data by Company
• 6.2 United States Anti-Venom Breakdown Data by Type
• 6.3 United States Anti-Venom Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-Venom Breakdown Data by Company
• 7.2 European Union Anti-Venom Breakdown Data by Type
• 7.3 European Union Anti-Venom Breakdown Data by Application

8 China

• 8.1 China Anti-Venom Breakdown Data by Company
• 8.2 China Anti-Venom Breakdown Data by Type
• 8.3 China Anti-Venom Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-Venom Breakdown Data by Company
• 9.2 Rest of World Anti-Venom Breakdown Data by Type
• 9.3 Rest of World Anti-Venom Breakdown Data by Application
• 9.4 Rest of World Anti-Venom Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-Venom Sales by Countries
  • 9.4.2 Rest of World Anti-Venom Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Medtoxin Venom Laboratories
  • 10.1.1 Medtoxin Venom Laboratories Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.1.4 Anti-Venom Product Introduction
  • 10.1.5 Medtoxin Venom Laboratories Recent Development
• 10.2 Institute of Immunology
  • 10.2.1 Institute of Immunology Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.2.4 Anti-Venom Product Introduction
  • 10.2.5 Institute of Immunology Recent Development
• 10.3 Alomone Labs
  • 10.3.1 Alomone Labs Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.3.4 Anti-Venom Product Introduction
  • 10.3.5 Alomone Labs Recent Development
• 10.4 Sigma Aldrich
  • 10.4.1 Sigma Aldrich Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.4.4 Anti-Venom Product Introduction
  • 10.4.5 Sigma Aldrich Recent Development
• 10.5 Wyeth Pharmaceuticals
  • 10.5.1 Wyeth Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.5.4 Anti-Venom Product Introduction
  • 10.5.5 Wyeth Pharmaceuticals Recent Development
• 10.6 Protherics PLC
  • 10.6.1 Protherics PLC Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.6.4 Anti-Venom Product Introduction
  • 10.6.5 Protherics PLC Recent Development
• 10.7 Bharat Serums and Vaccines
  • 10.7.1 Bharat Serums and Vaccines Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.7.4 Anti-Venom Product Introduction
  • 10.7.5 Bharat Serums and Vaccines Recent Development
• 10.8 Butantan Institute
  • 10.8.1 Butantan Institute Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.8.4 Anti-Venom Product Introduction
  • 10.8.5 Butantan Institute Recent Development
• 10.9 Haffkine Bio-Pharmaceutical Corporation
  • 10.9.1 Haffkine Bio-Pharmaceutical Corporation Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.9.4 Anti-Venom Product Introduction
  • 10.9.5 Haffkine Bio-Pharmaceutical Corporation Recent Development
• 10.10 Micropaharm Limited
  • 10.10.1 Micropaharm Limited Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Anti-Venom
  • 10.10.4 Anti-Venom Product Introduction
  • 10.10.5 Micropaharm Limited Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-Venom Sales Channels
  • 11.2.2 Anti-Venom Distributors
• 11.3 Anti-Venom Customers

12 Market Forecast

• 12.1 Global Anti-Venom Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-Venom Sales Forecast by Type
• 12.3 Global Anti-Venom Sales Forecast by Application
• 12.4 Anti-Venom Forecast by Regions
  • 12.4.1 Global Anti-Venom Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-Venom Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
In 2019, the market size of Anti-Venom is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Venom.

This report studies the global market size of Anti-Venom, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Venom sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Medtoxin Venom Laboratories
Institute of Immunology
Alomone Labs
Sigma Aldrich
Wyeth Pharmaceuticals
Protherics PLC
Bharat Serums and Vaccines
Butantan Institute
Haffkine Bio-Pharmaceutical Corporation
Micropaharm Limited

Market Segment by Product Type
Cytotoxic
Neurotoxic
Haemotoxic
Cardiotoxic
Myotoxic

Market Segment by Application
Snake
Spider
Scorpion

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-Venom status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Venom manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-Venom are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025